Abstract
Exo-2-amino-exo-3-aminomethylbicyclo[2.2.1]heptane (I) and 5-amino-exo-3-azatricyclo[5.2.1.02,6]decan-4-one (II) were synthesized and characterized with respect to antiarrhythmic activity. Compound II exhibited antiarrhythmic activity with ED50 = 0.28 and 0.33 mg/kg on the aconitine and calcium chloride models of arrhythmia, respectively. Compound I did not show antiarrhythmic activity and exhibited acute toxicity corresponding to LD50 = 450 mg/kg.
Similar content being viewed by others
REFERENCES
M. D. Mashkovskii, Drugs [in Russian], Torsing, Kharkov (1998), Vol. 1, pp. 370–388.
Proceedings of the 1st International Conference on the Chemistry and Biological Activity of Nitrous Heterocycles and Alkaloids [in Russian], G. A. Tolstyakov (ed.), Iridium Press, Moscow (2001), Vols. 1–2.
N. N. Yarmukhamedov, Author's Abstract of Cand. Sci. (Chem.) Thesis [in Russian], Ufa (2002).
A. M. Likhosherstov, O. V. Filippova, V. V. Peresada, et al., Khim.-Farm. Zh., 37(1), 8–11 (2003).
1-3-Dipolar Cycloaddition Chemistry, A. Padwa (ed.), Wiley, New York (1984), Vol. 2, pp. 439–441.
Organic Syntheses, J. Cason (ed.), New York (1957).
Author information
Authors and Affiliations
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 39, No. 6, pp. 9 – 11, June, 2005.
Rights and permissions
About this article
Cite this article
Gorpinchenko, V.A., Yatsynich, E.A., Petrov, D.V. et al. Synthesis and Antiarrhythmic Activity of 5-Amino-exo-3-azatricyclo[5.2.1.02,6]decan-4-one. Pharm Chem J 39, 289–291 (2005). https://doi.org/10.1007/s11094-005-0135-7
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-005-0135-7